{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:59:09Z","timestamp":1770339549417,"version":"3.49.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"10-13","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/j.steroids.2003.09.001","type":"journal-article","created":{"date-parts":[[2003,10,27]],"date-time":"2003-10-27T21:52:36Z","timestamp":1067291556000},"page":"921-926","source":"Crossref","is-referenced-by-count":13,"title":["Clinical experience with trimegestone as a new progestin in HRT"],"prefix":"10.1016","volume":"68","author":[{"given":"Gary","family":"Grubb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Spielmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Pickar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ginger","family":"Constantine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2003.09.001_BIB1","unstructured":"Winneker RC. The preclinical biology of trimegestone: a new potent and selective progestin. In: Second International Symposium on Progestins, Progesterone Receptor Modulators and Progesterone Antagonists; November 21, 2002."},{"key":"10.1016\/j.steroids.2003.09.001_BIB2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/08870449208404294","article-title":"The women\u2019s health questionnaire: a measure of mid-aged women\u2019s perceptions of their emotional and physical health","volume":"7","author":"Hunter","year":"1992","journal-title":"Psychol. Health"},{"key":"10.1016\/j.steroids.2003.09.001_BIB3","unstructured":"Genazzani AR, Gambacciani M, Spielmann D, The Trimegestone 301 Study Group. Efficacy on menopausal symptoms of continuous combined regimens of 1 mg 17\u03b2-estradiol and trimegestone compared with continuous combined regimens of estradiol and norethisterone acetate in postmenopausal women for up to 2 years. In: Paper Presented at the 10th World Menopause Congress, Berlin, June 2002. Climacteric 2002;5(Suppl 1):167."},{"key":"10.1016\/j.steroids.2003.09.001_BIB4","unstructured":"Dvorak V, Spielmann D, The Trimegestone 302 Study Group. A study of the control of climacteric symptoms in postmenopausal women following sequential regimens of estradiol and trimegestone compared with estradiol and norethisterone over a period of 2 years. In: Paper Presented at the 10th World Menopause Congress, Berlin, June 2002. Climacteric 2002;5(Suppl 1):130."},{"key":"10.1016\/j.steroids.2003.09.001_BIB5","unstructured":"Bouchard P, Addo S, Spielmann D, The Trimegestone 301 Study Group. A comparison of the effects of continuous combined regimens of 1 mg 17\u03b2-estradiol and trimegestone with continuous combined estradiol and norethisterone acetate upon the bleeding profile and safety in postmenopausal women for up to 2 years. In: Paper Presented at the 10th World Menopause Congress, Berlin, June 2002. Climacteric 2002;5(Suppl 1):145."},{"key":"10.1016\/j.steroids.2003.09.001_BIB6","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0015-0282(01)01792-7","article-title":"Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding","volume":"75","author":"Archer","year":"2001","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2003.09.001_BIB7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/713605133","article-title":"Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate","volume":"4","author":"Al-Azzawi","year":"2001","journal-title":"Climacteric"},{"key":"10.1016\/j.steroids.2003.09.001_BIB8","unstructured":"Koninckx P, Spielmann D, The Trimegestone 302 Study Group. A comparative 2-year study of two sequential regimens of 1 mg estradiol and trimegestone with 1 mg estradiol and norethisterone upon profiles of endometrial bleeding and safety in postmenopausal women. In: Paper Presented at the 10th World Menopause Congress, Berlin, June 2002. Climacteric 2002;5(Suppl 1):144."},{"key":"10.1016\/j.steroids.2003.09.001_BIB9","first-page":"686","article-title":"Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate","volume":"83","author":"Archer","year":"1994","journal-title":"Obstet. Gynecol."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X03001764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X03001764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T09:58:34Z","timestamp":1550483914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X03001764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":9,"journal-issue":{"issue":"10-13","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0039128X03001764"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2003.09.001","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}